Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Gazzard

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|March 25, 2006
Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patientsBrian G Gazzard
Journal of HIV Therapy|October 28, 2008
Controversies in current treatment guidelinesBrian G Gazzard
Journal of HIV Therapy|May 8, 2003
Clinical utility of resistance testingJustin Stebbing, Brian G Gazzard
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme Moyle
BMJ (Clinical Research Ed.)|February 12, 2005
Rising rates of HIV infectionAngela J Robinson, Brian G Gazzard
AIDS (London, England)|April 16, 2002
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysisGraeme J Moyle, Brian G Gazzard
AIDS (London, England)|January 25, 2002
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcomeJohn C Walsh, Sundhiya Mandalia, Brian G Gazzard
International Journal of STD & AIDS|September 17, 2002
A case of march fracture in a patient with osteoporosis on long-term HAARTSophie F Forsyth, Brian G Gazzard, Mark R Nelson
Journal of HIV Therapy|April 17, 2002
Opportunistic protozoan diarrhoeaYin M Miao, Faith M Awad-El-Kariem, Brian G Gazzard
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|March 25, 2006
Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patientsBrian G Gazzard
Journal of HIV Therapy|October 28, 2008
Controversies in current treatment guidelinesBrian G Gazzard
Journal of HIV Therapy|May 8, 2003
Clinical utility of resistance testingJustin Stebbing, Brian G Gazzard
Journal of HIV Therapy|July 9, 2004
Does atazanavir cause lipodystrophy?Brian G Gazzard, Graeme Moyle
BMJ (Clinical Research Ed.)|February 12, 2005
Rising rates of HIV infectionAngela J Robinson, Brian G Gazzard
AIDS (London, England)|April 16, 2002
Switching to zidovudine plus lamivudine plus abacavir maintains viral suppression in patients with high viral load before antiretroviral therapy: a retrospective clinical cohort analysisGraeme J Moyle, Brian G Gazzard
AIDS (London, England)|January 25, 2002
Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcomeJohn C Walsh, Sundhiya Mandalia, Brian G Gazzard
International Journal of STD & AIDS|September 17, 2002
A case of march fracture in a patient with osteoporosis on long-term HAARTSophie F Forsyth, Brian G Gazzard, Mark R Nelson
Journal of HIV Therapy|April 17, 2002
Opportunistic protozoan diarrhoeaYin M Miao, Faith M Awad-El-Kariem, Brian G Gazzard
AIDS (London, England)|March 2, 2002
Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphomaTom Powles, Nesrina Imami, Mark Nelson, et al.
Pageof 5